Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy

Journal of Experimental Medicine

Volumn 204, Issue 4, 2007, Pages 831-840

  Spisek, Radek ^a   Kukreja, Anjli ^a   Chen, Lin Chi ^b   Matthews, Phillip ^a   Mazumder, Amitabha ^d   Vesole, David ^d   Jagannath, Sundar ^d   Zebroski, Henry A ^a   Simpson, Andrew J G ^c   Ritter, Gerd ^c   Durie, Brian ^f   Crowley, John ^e   Shaughnessy Jr , John D ^g   Scanlan, Matthew J ^c   Gure, Ali O ^c,h   Barlogie, Bart ^g   Dhodapkar, Madhav V ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^d ST VINCENT S COMPREHENSIVE CANCER CENTER   (United States)

^e SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER   (United States)

^f CEDARS SINAI MEDICAL CENTER   (United States)

^g UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^h BILKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

SYNDECAN 1; TRANSCRIPTION FACTOR SOX2;

ADAPTIVE IMMUNITY; ARTICLE; CELL GROWTH; CELLULAR IMMUNITY; CONTROLLED STUDY; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; MONOCLONAL IMMUNOGLOBULINEMIA; MYELOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BIOLOGICAL MARKERS; CELL PROLIFERATION; CELLS, CULTURED; DISEASE PROGRESSION; EMBRYONIC STEM CELLS; HEALTH; HMGB PROTEINS; HUMANS; IMMUNOGLOBULIN G; MULTIPLE MYELOMA; NEOPLASMS; PARAPROTEINEMIAS; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; TREATMENT OUTCOME;

EID: 34247339604     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20062387     Document Type: Article

References (34)

1. Dunn, G.P., A.T. Bruce, H. Ikeda, L.J. Old, and R.D. Schreiber. 2002. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3:991-998.
2. Blattman, J.N., and P.D. Greenberg. 2004. Cancer immunotherapy: a treatment for the masses. Science. 305:200-205.
3. Finn, O.J. 2003. Premalignant lesions as targets for cancer vaccines. J. Exp. Med. 198:1623-1626.
4. Dhodapkar, M.V. 2005. Harnessing host immune responses to preneoplasia: promise and challenges. Cancer Immunol. Immunother. 54:409-413.
5. Kyle, R.A., T.M. Therneau, S.V. Rajkumar, D.R. Larson, M.F. Plevak, J.R. Offord, A. Dispenzieri, J.A. Katzmann, and L.J. Melton III. 2006. Prevalence of monoclonal gammopathy of undetermined significance. N. Engl. J. Med. 354:1362-1369.
6. Fonseca, R., B. Barlogie, R. Bataille, C. Bastard, P.L. Bergsagel, M. Chesi, F.E. Davies, J. Drach, P.R. Greipp, I.R. Kirsch, et al. 2004. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res. 64:1546-1558.
7. Reya, T., S.J. Morrison, M.F. Clarke, and I.L. Weissman. 2001. Stem cells, cancer, and cancer stem cells. Nature. 414:105-111.
8. Matsui, W., C.A. Huff , Q. Wang, M.T. Malehorn, J. Barber, Y. Tanhehco, B.D. Smith, C.I. Civin, and R.J. Jones. 2004. Characterization of clonogenic multiple myeloma cells. Blood. 103:2332-2336.
9. Kukreja, A., A. Hutchinson, K. Dhodapkar, A. Mazumder, D. Vesole, R. Angitapalli, S. Jagannath, and M.V. Dhodapkar. 2006. Enhancement of clonogenicity of human multiple myeloma by dendritic cells. J. Exp. Med. 203:1859-1865.
10. Dhodapkar, M.V., J. Krasovsky, K. Osman, and M.D. Geller. 2003. Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy. J. Exp. Med. 198:1753-1757.
11. Wegner, M., and C.C. Stolt. 2005. From stem cells to neurons and glia: a Soxist's view of neural development. Trends Neurosci. 28:583-588.
12. Tatematsu, M., T. Tsukamoto, and K. Inada. 2003. Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci. 94:135-141.
13. Hemmati, H.D., I. Nakano, J.A. Lazareff , M. Masterman-Smith, D.H. Geschwind, M. Bronner-Fraser, and H.I. Kornblum. 2003. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. USA. 100:15178-15183.
14. Boyer, L.A., T.I. Lee, M.F. Cole, S.E. Johnstone, S.S. Levine, J.P. Zucker, M.G. Guenther, R.M. Kumar, H.L. Murray, R.G. Jenner, et al. 2005. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 122:947-956.
15. Takahashi, K., and S. Yamanaka. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126:663-676.
16. McHeyzer-Williams, L.J., and M.G. McHeyzer-Williams. 2005. Antigen-specific memory B cell development. Annu. Rev. Immunol. 23:487-513.
17. Suzuki, H., D.F. Graziano, J. McKolanis, and O.J. Finn. 2005. T celldependent antibody responses against aberrantly expressed cyclin B1 protein in patients with cancer and premalignant disease. Clin. Cancer Res. 11:1521-1526.
18. Comtesse, N., A. Zippel, S. Walle, D. Monz, C. Backes, U. Fischer, J. Mayer, N. Ludwig, A. Hildebrandt, A. Keller, et al. 2005. Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets. Proc. Natl. Acad. Sci. USA. 102:9601-9606.
19. Spisek, R., and M.V. Dhodapkar. 2006. Immunoprevention of cancer. Hematol. Oncol. Clin. North Am. 20:735-750.
20. Forni, G., P.L. Lollini, P. Musiani, and M.P. Colombo. 2000. Immunoprevention of cancer: is the time ripe? Cancer Res. 60:2571-2575.
21. Jamieson, C.H., L.E. Ailles, S.J. Dylla, M. Muijtjens, C. Jones, J.L. Zehnder, J. Gotlib, K. Li, M.G. Manz, A. Keating, et al. 2004. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351:657-667.
22. Jamieson, C.H., I.L. Weissman, and E. Passegue. 2004. Chronic versus acute myelogenous leukemia: a question of self-renewal. Cancer Cell. 6:531-533.
23. de Visser, K.E., A. Eichten, and L.M. Coussens. 2006. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer. 6:24-37.
24. Gure, A.O., E. Stockert, M.J. Scanlan, R.S. Keresztes, D. Jager, N.K. Altorki, L.J. Old, and Y.T. Chen. 2000. Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc. Natl. Acad. Sci. USA. 97:4198-4203.
25. Vural, B., L.C. Chen, P. Saip, Y.T. Chen, Z. Ustuner, M. Gonen, A.J. Simpson, L.J. Old, U. Ozbek, and A.O. Gure. 2005. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters. Cancer. 103:2575-2583.
26. Kyle, R.A. 2004. New Strategies for MGUS and Smoldering Multiple Myeloma. Clin. Adv. Hematol. Oncol. 2:507-509.
27. Durie, B.G., R.A. Kyle, A. Belch, W. Bensinger, J. Blade, M. Boccadoro, J.A. Child, R. Comenzo, B. Djulbegovic, D. Fantl, et al. 2003. Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol. J. 4:379-398.
28. Dhodapkar, K., J. Krasovsky, B. Williamson, and M. Dhodapkar. 2002. Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of tumor-specific killer T cells by dendritic cells. J. Exp. Med. 195:125-133.
29. Chen, Y.T., A.O. Gure, and M.J. Scanlan. 2005. Serological analysis of expression cDNA libraries (SEREX): an immunoscreening technique for identifying immunogenic tumor antigens. Methods Mol. Med. 103:207-216.
30. Dhodapkar, K.M., J.L. Kaufman, M. Ehlers, D.K. Banerjee, E. Bonvini, S. Koenig, R.M. Steinman, J.V. Ravetch, and M.V. Dhodapkar. 2005. Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells. Proc. Natl. Acad. Sci. USA. 102:2910-2915.
31. Chang, D.H., K. Osman, J. Connolly, A. Kukreja, J. Krasovsky, M. Pack, A. Hutchinson, M. Geller, N. Liu, R. Annable, et al. 2005. Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl- ceramide-loaded mature dendritic cells in cancer patients. J. Exp. Med. 201:1503-1517.
32. Durie, B.G., J.L. Harousseau, J.S. Miguel, J. Blade, B. Barlogie, K. Anderson, M. Gertz, M. Dimopoulos, J. Westin, P. Sonneveld, et al. 2006. International uniform response criteria for multiple myeloma. Leukemia. 20:1467-1473.
33. Kaplan, E.L., and P. Meier. 1958. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481.
34. Mantel, N. 1966. Evaluation of survival data and two new rank order statistics arising in its evaluation. Cancer Chemother. Rep. 50:163-170.